Global AI in Pharmaceutical Supply, Demand and Key Producers, 2026-2032
The global AI in Pharmaceutical market size is expected to reach $ 26364 million by 2032, rising at a market growth of 15.6% CAGR during the forecast period (2026-2032).
AI in Pharmaceutical refers to the application of artificial intelligence technologies, including machine learning, deep learning, natural language processing, computer vision, predictive analytics, and generative AI, across pharmaceutical research, drug discovery, clinical development, manufacturing, regulatory compliance, supply chain management, and commercial operations to improve efficiency, reduce development costs, accelerate drug commercialization, optimize decision-making, and enhance precision medicine capabilities within the pharmaceutical industry.
Current and planned AI in Pharmaceutical projects globally include large-scale AI drug discovery platforms, generative AI molecular design laboratories, pharmaceutical cloud computing infrastructure expansion projects, precision medicine analytics centers, AI-assisted clinical trial optimization programs, digital twin pharmaceutical manufacturing initiatives, intelligent biologics development facilities, collaborative AI-biotech research partnerships, pharmaceutical real-world data integration projects, automated regulatory compliance systems, AI-powered genomic medicine platforms, smart pharmaceutical supply chain management projects, AI-driven biomarker discovery programs, healthcare data lake construction projects, and advanced computational biology research centers intended to accelerate pharmaceutical innovation, reduce drug development timelines, improve clinical success rates, and strengthen data-driven healthcare commercialization capabilities worldwide.
2025 Global Market Average Gross Profit Margin: 58%.
The AI in Pharmaceutical market is experiencing rapid expansion as pharmaceutical companies increasingly adopt artificial intelligence technologies to improve drug discovery efficiency, reduce R&D costs, accelerate clinical development timelines, and enhance commercialization capabilities. Traditional pharmaceutical development processes are expensive, time-consuming, and characterized by high failure rates, creating strong demand for AI-driven predictive analytics and automation solutions. AI technologies are being widely integrated into molecular screening, biomarker discovery, target identification, toxicity prediction, and clinical trial optimization workflows. The growing availability of biomedical datasets, genomic sequencing technologies, cloud computing infrastructure, and high-performance computing resources has significantly accelerated AI adoption across the pharmaceutical sector. Generative AI models capable of designing novel molecular structures and simulating drug interactions are becoming increasingly important in next-generation pharmaceutical research strategies.
From a regional perspective, North America currently dominates the market due to strong pharmaceutical R&D investment, advanced digital infrastructure, abundant venture capital funding, and the presence of major AI and biotechnology companies. The United States represents the largest innovation hub for pharmaceutical AI development, supported by leading research institutions and strategic collaborations between pharmaceutical companies and AI startups. Europe maintains a strong market position driven by advanced healthcare systems, pharmaceutical manufacturing expertise, and increasing regulatory support for digital healthcare transformation. Asia-Pacific is emerging as the fastest-growing region due to expanding pharmaceutical manufacturing capacity, increasing healthcare digitization, government AI initiatives, and growing biotechnology investments in China, Japan, South Korea, and India. China is rapidly strengthening its position through large-scale healthcare data resources and aggressive AI commercialization programs.
The market presents substantial growth opportunities driven by increasing demand for precision medicine, personalized therapies, biologics development, and rare disease research. AI significantly reduces candidate screening timelines and improves drug development efficiency, making it highly attractive for pharmaceutical companies facing rising R&D expenditures and patent expiration pressures. The expansion of cloud-based AI platforms and AI-as-a-Service business models is lowering technology adoption barriers for small and mid-sized pharmaceutical firms. In addition, growing interest in decentralized clinical trials, digital therapeutics, and real-world evidence analytics is creating new application opportunities for pharmaceutical AI platforms. Strategic collaborations between pharmaceutical companies, AI developers, and healthcare institutions are expected to further accelerate innovation and commercialization.
This report studies the global AI in Pharmaceutical demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI in Pharmaceutical, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI in Pharmaceutical that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI in Pharmaceutical total market, 2021-2032, (USD Million)
Global AI in Pharmaceutical total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: AI in Pharmaceutical total market, key domestic companies, and share, (USD Million)
Global AI in Pharmaceutical revenue by player, revenue and market share 2021-2026, (USD Million)
Global AI in Pharmaceutical total market by Deployment Type, CAGR, 2021-2032, (USD Million)
Global AI in Pharmaceutical total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global AI in Pharmaceutical market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cradle, Prezent, Insilico Medicine, Owkin, Inc, Certara, PathAI, Inc, Aizon, Salesforce, Inc, Aidoc, IQVIA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world AI in Pharmaceutical market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Deployment Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global AI in Pharmaceutical Market, By Region:
1. How big is the global AI in Pharmaceutical market?
2. What is the demand of the global AI in Pharmaceutical market?
3. What is the year over year growth of the global AI in Pharmaceutical market?
4. What is the total value of the global AI in Pharmaceutical market?
5. Who are the Major Players in the global AI in Pharmaceutical market?
6. What are the growth factors driving the market demand?
AI in Pharmaceutical refers to the application of artificial intelligence technologies, including machine learning, deep learning, natural language processing, computer vision, predictive analytics, and generative AI, across pharmaceutical research, drug discovery, clinical development, manufacturing, regulatory compliance, supply chain management, and commercial operations to improve efficiency, reduce development costs, accelerate drug commercialization, optimize decision-making, and enhance precision medicine capabilities within the pharmaceutical industry.
Current and planned AI in Pharmaceutical projects globally include large-scale AI drug discovery platforms, generative AI molecular design laboratories, pharmaceutical cloud computing infrastructure expansion projects, precision medicine analytics centers, AI-assisted clinical trial optimization programs, digital twin pharmaceutical manufacturing initiatives, intelligent biologics development facilities, collaborative AI-biotech research partnerships, pharmaceutical real-world data integration projects, automated regulatory compliance systems, AI-powered genomic medicine platforms, smart pharmaceutical supply chain management projects, AI-driven biomarker discovery programs, healthcare data lake construction projects, and advanced computational biology research centers intended to accelerate pharmaceutical innovation, reduce drug development timelines, improve clinical success rates, and strengthen data-driven healthcare commercialization capabilities worldwide.
2025 Global Market Average Gross Profit Margin: 58%.
The AI in Pharmaceutical market is experiencing rapid expansion as pharmaceutical companies increasingly adopt artificial intelligence technologies to improve drug discovery efficiency, reduce R&D costs, accelerate clinical development timelines, and enhance commercialization capabilities. Traditional pharmaceutical development processes are expensive, time-consuming, and characterized by high failure rates, creating strong demand for AI-driven predictive analytics and automation solutions. AI technologies are being widely integrated into molecular screening, biomarker discovery, target identification, toxicity prediction, and clinical trial optimization workflows. The growing availability of biomedical datasets, genomic sequencing technologies, cloud computing infrastructure, and high-performance computing resources has significantly accelerated AI adoption across the pharmaceutical sector. Generative AI models capable of designing novel molecular structures and simulating drug interactions are becoming increasingly important in next-generation pharmaceutical research strategies.
From a regional perspective, North America currently dominates the market due to strong pharmaceutical R&D investment, advanced digital infrastructure, abundant venture capital funding, and the presence of major AI and biotechnology companies. The United States represents the largest innovation hub for pharmaceutical AI development, supported by leading research institutions and strategic collaborations between pharmaceutical companies and AI startups. Europe maintains a strong market position driven by advanced healthcare systems, pharmaceutical manufacturing expertise, and increasing regulatory support for digital healthcare transformation. Asia-Pacific is emerging as the fastest-growing region due to expanding pharmaceutical manufacturing capacity, increasing healthcare digitization, government AI initiatives, and growing biotechnology investments in China, Japan, South Korea, and India. China is rapidly strengthening its position through large-scale healthcare data resources and aggressive AI commercialization programs.
The market presents substantial growth opportunities driven by increasing demand for precision medicine, personalized therapies, biologics development, and rare disease research. AI significantly reduces candidate screening timelines and improves drug development efficiency, making it highly attractive for pharmaceutical companies facing rising R&D expenditures and patent expiration pressures. The expansion of cloud-based AI platforms and AI-as-a-Service business models is lowering technology adoption barriers for small and mid-sized pharmaceutical firms. In addition, growing interest in decentralized clinical trials, digital therapeutics, and real-world evidence analytics is creating new application opportunities for pharmaceutical AI platforms. Strategic collaborations between pharmaceutical companies, AI developers, and healthcare institutions are expected to further accelerate innovation and commercialization.
This report studies the global AI in Pharmaceutical demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI in Pharmaceutical, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI in Pharmaceutical that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI in Pharmaceutical total market, 2021-2032, (USD Million)
Global AI in Pharmaceutical total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: AI in Pharmaceutical total market, key domestic companies, and share, (USD Million)
Global AI in Pharmaceutical revenue by player, revenue and market share 2021-2026, (USD Million)
Global AI in Pharmaceutical total market by Deployment Type, CAGR, 2021-2032, (USD Million)
Global AI in Pharmaceutical total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global AI in Pharmaceutical market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cradle, Prezent, Insilico Medicine, Owkin, Inc, Certara, PathAI, Inc, Aizon, Salesforce, Inc, Aidoc, IQVIA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world AI in Pharmaceutical market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Deployment Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global AI in Pharmaceutical Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Cloud-Based AI Solutions
- On-Premises AI Platforms
- Machine Learning AI
- Deep Learning AI
- Natural Language Processing (NLP)
- Computer Vision AI
- Others
- Drug Discovery AI Platforms
- Clinical Trial AI Systems
- Manufacturing Process AI
- Regulatory Compliance AI
- Others
- Drug Discovery and Design
- Biomarker Identification
- Clinical Trial Optimization
- Manufacturing Process Optimization
- Others
- Cradle
- Prezent
- Insilico Medicine
- Owkin, Inc
- Certara
- PathAI, Inc
- Aizon
- Salesforce, Inc
- Aidoc
- IQVIA
- ISOMORPHIC LABS
- ConcertAI
- Nexocode
- BenevolentAI
- Recursion
- Iktos
- XtalPi Inc
1. How big is the global AI in Pharmaceutical market?
2. What is the demand of the global AI in Pharmaceutical market?
3. What is the year over year growth of the global AI in Pharmaceutical market?
4. What is the total value of the global AI in Pharmaceutical market?
5. Who are the Major Players in the global AI in Pharmaceutical market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 AI in Pharmaceutical Introduction
1.2 World AI in Pharmaceutical Market Size & Forecast (2021 & 2025 & 2032)
1.3 World AI in Pharmaceutical Total Market by Region (by Headquarter Location)
1.3.1 World AI in Pharmaceutical Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company AI in Pharmaceutical Revenue (2021-2032)
1.3.3 China Based Company AI in Pharmaceutical Revenue (2021-2032)
1.3.4 Europe Based Company AI in Pharmaceutical Revenue (2021-2032)
1.3.5 Japan Based Company AI in Pharmaceutical Revenue (2021-2032)
1.3.6 South Korea Based Company AI in Pharmaceutical Revenue (2021-2032)
1.3.7 ASEAN Based Company AI in Pharmaceutical Revenue (2021-2032)
1.3.8 India Based Company AI in Pharmaceutical Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI in Pharmaceutical Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World AI in Pharmaceutical Consumption Value (2021-2032)
2.2 World AI in Pharmaceutical Consumption Value by Region
2.2.1 World AI in Pharmaceutical Consumption Value by Region (2021-2026)
2.2.2 World AI in Pharmaceutical Consumption Value Forecast by Region (2027-2032)
2.3 United States AI in Pharmaceutical Consumption Value (2021-2032)
2.4 China AI in Pharmaceutical Consumption Value (2021-2032)
2.5 Europe AI in Pharmaceutical Consumption Value (2021-2032)
2.6 Japan AI in Pharmaceutical Consumption Value (2021-2032)
2.7 South Korea AI in Pharmaceutical Consumption Value (2021-2032)
2.8 ASEAN AI in Pharmaceutical Consumption Value (2021-2032)
2.9 India AI in Pharmaceutical Consumption Value (2021-2032)
3 WORLD AI IN PHARMACEUTICAL COMPANIES COMPETITIVE ANALYSIS
3.1 World AI in Pharmaceutical Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI in Pharmaceutical Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI in Pharmaceutical in 2025
3.2.3 Global Concentration Ratios (CR8) for AI in Pharmaceutical in 2025
3.3 AI in Pharmaceutical Company Evaluation Quadrant
3.4 AI in Pharmaceutical Market: Overall Company Footprint Analysis
3.4.1 AI in Pharmaceutical Market: Region Footprint
3.4.2 AI in Pharmaceutical Market: Company Product Type Footprint
3.4.3 AI in Pharmaceutical Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI in Pharmaceutical Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI in Pharmaceutical Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: AI in Pharmaceutical Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: AI in Pharmaceutical Consumption Value Comparison
4.2.1 United States VS China: AI in Pharmaceutical Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: AI in Pharmaceutical Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based AI in Pharmaceutical Companies and Market Share, 2021-2026
4.3.1 United States Based AI in Pharmaceutical Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI in Pharmaceutical Revenue, (2021-2026)
4.4 China Based Companies AI in Pharmaceutical Revenue and Market Share, 2021-2026
4.4.1 China Based AI in Pharmaceutical Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI in Pharmaceutical Revenue, (2021-2026)
4.5 Rest of World Based AI in Pharmaceutical Companies and Market Share, 2021-2026
4.5.1 Rest of World Based AI in Pharmaceutical Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies AI in Pharmaceutical Revenue (2021-2026)
5 MARKET ANALYSIS BY DEPLOYMENT TYPE
5.1 World AI in Pharmaceutical Market Size Overview by Deployment Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Deployment Type
5.2.1 Cloud-Based AI Solutions
5.2.2 On-Premises AI Platforms
5.3 Market Segment by Deployment Type
5.3.1 World AI in Pharmaceutical Market Size by Deployment Type (2021-2026)
5.3.2 World AI in Pharmaceutical Market Size by Deployment Type (2027-2032)
5.3.3 World AI in Pharmaceutical Market Size Market Share by Deployment Type (2027-2032)
6 MARKET ANALYSIS BY TECHNOLOGY TYPE
6.1 World AI in Pharmaceutical Market Size Overview by Technology Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Technology Type
6.2.1 Machine Learning AI
6.2.2 Deep Learning AI
6.2.3 Natural Language Processing (NLP)
6.2.4 Computer Vision AI
6.2.5 Others
6.3 Market Segment by Technology Type
6.3.1 World AI in Pharmaceutical Market Size by Technology Type (2021-2026)
6.3.2 World AI in Pharmaceutical Market Size by Technology Type (2027-2032)
6.3.3 World AI in Pharmaceutical Market Size Market Share by Technology Type (2027-2032)
7 MARKET ANALYSIS BY FUNCTIONAL INTEGRATION TYPE
7.1 World AI in Pharmaceutical Market Size Overview by Functional Integration Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Functional Integration Type
7.2.1 Drug Discovery AI Platforms
7.2.2 Clinical Trial AI Systems
7.2.3 Manufacturing Process AI
7.2.4 Regulatory Compliance AI
7.2.5 Others
7.3 Market Segment by Functional Integration Type
7.3.1 World AI in Pharmaceutical Market Size by Functional Integration Type (2021-2026)
7.3.2 World AI in Pharmaceutical Market Size by Functional Integration Type (2027-2032)
7.3.3 World AI in Pharmaceutical Market Size Market Share by Functional Integration Type (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World AI in Pharmaceutical Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Drug Discovery and Design
8.2.2 Biomarker Identification
8.2.3 Clinical Trial Optimization
8.2.4 Manufacturing Process Optimization
8.2.5 Others
8.3 Market Segment by Application
8.3.1 World AI in Pharmaceutical Market Size by Application (2021-2026)
8.3.2 World AI in Pharmaceutical Market Size by Application (2027-2032)
8.3.3 World AI in Pharmaceutical Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Cradle
9.1.1 Cradle Details
9.1.2 Cradle Major Business
9.1.3 Cradle AI in Pharmaceutical Product and Services
9.1.4 Cradle AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Cradle Recent Developments/Updates
9.1.6 Cradle Competitive Strengths & Weaknesses
9.2 Prezent
9.2.1 Prezent Details
9.2.2 Prezent Major Business
9.2.3 Prezent AI in Pharmaceutical Product and Services
9.2.4 Prezent AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Prezent Recent Developments/Updates
9.2.6 Prezent Competitive Strengths & Weaknesses
9.3 Insilico Medicine
9.3.1 Insilico Medicine Details
9.3.2 Insilico Medicine Major Business
9.3.3 Insilico Medicine AI in Pharmaceutical Product and Services
9.3.4 Insilico Medicine AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Insilico Medicine Recent Developments/Updates
9.3.6 Insilico Medicine Competitive Strengths & Weaknesses
9.4 Owkin, Inc
9.4.1 Owkin, Inc Details
9.4.2 Owkin, Inc Major Business
9.4.3 Owkin, Inc AI in Pharmaceutical Product and Services
9.4.4 Owkin, Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Owkin, Inc Recent Developments/Updates
9.4.6 Owkin, Inc Competitive Strengths & Weaknesses
9.5 Certara
9.5.1 Certara Details
9.5.2 Certara Major Business
9.5.3 Certara AI in Pharmaceutical Product and Services
9.5.4 Certara AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Certara Recent Developments/Updates
9.5.6 Certara Competitive Strengths & Weaknesses
9.6 PathAI, Inc
9.6.1 PathAI, Inc Details
9.6.2 PathAI, Inc Major Business
9.6.3 PathAI, Inc AI in Pharmaceutical Product and Services
9.6.4 PathAI, Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 PathAI, Inc Recent Developments/Updates
9.6.6 PathAI, Inc Competitive Strengths & Weaknesses
9.7 Aizon
9.7.1 Aizon Details
9.7.2 Aizon Major Business
9.7.3 Aizon AI in Pharmaceutical Product and Services
9.7.4 Aizon AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Aizon Recent Developments/Updates
9.7.6 Aizon Competitive Strengths & Weaknesses
9.8 Salesforce, Inc
9.8.1 Salesforce, Inc Details
9.8.2 Salesforce, Inc Major Business
9.8.3 Salesforce, Inc AI in Pharmaceutical Product and Services
9.8.4 Salesforce, Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Salesforce, Inc Recent Developments/Updates
9.8.6 Salesforce, Inc Competitive Strengths & Weaknesses
9.9 Aidoc
9.9.1 Aidoc Details
9.9.2 Aidoc Major Business
9.9.3 Aidoc AI in Pharmaceutical Product and Services
9.9.4 Aidoc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Aidoc Recent Developments/Updates
9.9.6 Aidoc Competitive Strengths & Weaknesses
9.10 IQVIA
9.10.1 IQVIA Details
9.10.2 IQVIA Major Business
9.10.3 IQVIA AI in Pharmaceutical Product and Services
9.10.4 IQVIA AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 IQVIA Recent Developments/Updates
9.10.6 IQVIA Competitive Strengths & Weaknesses
9.11 ISOMORPHIC LABS
9.11.1 ISOMORPHIC LABS Details
9.11.2 ISOMORPHIC LABS Major Business
9.11.3 ISOMORPHIC LABS AI in Pharmaceutical Product and Services
9.11.4 ISOMORPHIC LABS AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 ISOMORPHIC LABS Recent Developments/Updates
9.11.6 ISOMORPHIC LABS Competitive Strengths & Weaknesses
9.12 ConcertAI
9.12.1 ConcertAI Details
9.12.2 ConcertAI Major Business
9.12.3 ConcertAI AI in Pharmaceutical Product and Services
9.12.4 ConcertAI AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 ConcertAI Recent Developments/Updates
9.12.6 ConcertAI Competitive Strengths & Weaknesses
9.13 Nexocode
9.13.1 Nexocode Details
9.13.2 Nexocode Major Business
9.13.3 Nexocode AI in Pharmaceutical Product and Services
9.13.4 Nexocode AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Nexocode Recent Developments/Updates
9.13.6 Nexocode Competitive Strengths & Weaknesses
9.14 BenevolentAI
9.14.1 BenevolentAI Details
9.14.2 BenevolentAI Major Business
9.14.3 BenevolentAI AI in Pharmaceutical Product and Services
9.14.4 BenevolentAI AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 BenevolentAI Recent Developments/Updates
9.14.6 BenevolentAI Competitive Strengths & Weaknesses
9.15 Recursion
9.15.1 Recursion Details
9.15.2 Recursion Major Business
9.15.3 Recursion AI in Pharmaceutical Product and Services
9.15.4 Recursion AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Recursion Recent Developments/Updates
9.15.6 Recursion Competitive Strengths & Weaknesses
9.16 Iktos
9.16.1 Iktos Details
9.16.2 Iktos Major Business
9.16.3 Iktos AI in Pharmaceutical Product and Services
9.16.4 Iktos AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Iktos Recent Developments/Updates
9.16.6 Iktos Competitive Strengths & Weaknesses
9.17 XtalPi Inc
9.17.1 XtalPi Inc Details
9.17.2 XtalPi Inc Major Business
9.17.3 XtalPi Inc AI in Pharmaceutical Product and Services
9.17.4 XtalPi Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 XtalPi Inc Recent Developments/Updates
9.17.6 XtalPi Inc Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 AI in Pharmaceutical Industry Chain
10.2 AI in Pharmaceutical Upstream Analysis
10.3 AI in Pharmaceutical Midstream Analysis
10.4 AI in Pharmaceutical Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 AI in Pharmaceutical Introduction
1.2 World AI in Pharmaceutical Market Size & Forecast (2021 & 2025 & 2032)
1.3 World AI in Pharmaceutical Total Market by Region (by Headquarter Location)
1.3.1 World AI in Pharmaceutical Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company AI in Pharmaceutical Revenue (2021-2032)
1.3.3 China Based Company AI in Pharmaceutical Revenue (2021-2032)
1.3.4 Europe Based Company AI in Pharmaceutical Revenue (2021-2032)
1.3.5 Japan Based Company AI in Pharmaceutical Revenue (2021-2032)
1.3.6 South Korea Based Company AI in Pharmaceutical Revenue (2021-2032)
1.3.7 ASEAN Based Company AI in Pharmaceutical Revenue (2021-2032)
1.3.8 India Based Company AI in Pharmaceutical Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI in Pharmaceutical Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World AI in Pharmaceutical Consumption Value (2021-2032)
2.2 World AI in Pharmaceutical Consumption Value by Region
2.2.1 World AI in Pharmaceutical Consumption Value by Region (2021-2026)
2.2.2 World AI in Pharmaceutical Consumption Value Forecast by Region (2027-2032)
2.3 United States AI in Pharmaceutical Consumption Value (2021-2032)
2.4 China AI in Pharmaceutical Consumption Value (2021-2032)
2.5 Europe AI in Pharmaceutical Consumption Value (2021-2032)
2.6 Japan AI in Pharmaceutical Consumption Value (2021-2032)
2.7 South Korea AI in Pharmaceutical Consumption Value (2021-2032)
2.8 ASEAN AI in Pharmaceutical Consumption Value (2021-2032)
2.9 India AI in Pharmaceutical Consumption Value (2021-2032)
3 WORLD AI IN PHARMACEUTICAL COMPANIES COMPETITIVE ANALYSIS
3.1 World AI in Pharmaceutical Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI in Pharmaceutical Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI in Pharmaceutical in 2025
3.2.3 Global Concentration Ratios (CR8) for AI in Pharmaceutical in 2025
3.3 AI in Pharmaceutical Company Evaluation Quadrant
3.4 AI in Pharmaceutical Market: Overall Company Footprint Analysis
3.4.1 AI in Pharmaceutical Market: Region Footprint
3.4.2 AI in Pharmaceutical Market: Company Product Type Footprint
3.4.3 AI in Pharmaceutical Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI in Pharmaceutical Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI in Pharmaceutical Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: AI in Pharmaceutical Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: AI in Pharmaceutical Consumption Value Comparison
4.2.1 United States VS China: AI in Pharmaceutical Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: AI in Pharmaceutical Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based AI in Pharmaceutical Companies and Market Share, 2021-2026
4.3.1 United States Based AI in Pharmaceutical Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI in Pharmaceutical Revenue, (2021-2026)
4.4 China Based Companies AI in Pharmaceutical Revenue and Market Share, 2021-2026
4.4.1 China Based AI in Pharmaceutical Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI in Pharmaceutical Revenue, (2021-2026)
4.5 Rest of World Based AI in Pharmaceutical Companies and Market Share, 2021-2026
4.5.1 Rest of World Based AI in Pharmaceutical Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies AI in Pharmaceutical Revenue (2021-2026)
5 MARKET ANALYSIS BY DEPLOYMENT TYPE
5.1 World AI in Pharmaceutical Market Size Overview by Deployment Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Deployment Type
5.2.1 Cloud-Based AI Solutions
5.2.2 On-Premises AI Platforms
5.3 Market Segment by Deployment Type
5.3.1 World AI in Pharmaceutical Market Size by Deployment Type (2021-2026)
5.3.2 World AI in Pharmaceutical Market Size by Deployment Type (2027-2032)
5.3.3 World AI in Pharmaceutical Market Size Market Share by Deployment Type (2027-2032)
6 MARKET ANALYSIS BY TECHNOLOGY TYPE
6.1 World AI in Pharmaceutical Market Size Overview by Technology Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Technology Type
6.2.1 Machine Learning AI
6.2.2 Deep Learning AI
6.2.3 Natural Language Processing (NLP)
6.2.4 Computer Vision AI
6.2.5 Others
6.3 Market Segment by Technology Type
6.3.1 World AI in Pharmaceutical Market Size by Technology Type (2021-2026)
6.3.2 World AI in Pharmaceutical Market Size by Technology Type (2027-2032)
6.3.3 World AI in Pharmaceutical Market Size Market Share by Technology Type (2027-2032)
7 MARKET ANALYSIS BY FUNCTIONAL INTEGRATION TYPE
7.1 World AI in Pharmaceutical Market Size Overview by Functional Integration Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Functional Integration Type
7.2.1 Drug Discovery AI Platforms
7.2.2 Clinical Trial AI Systems
7.2.3 Manufacturing Process AI
7.2.4 Regulatory Compliance AI
7.2.5 Others
7.3 Market Segment by Functional Integration Type
7.3.1 World AI in Pharmaceutical Market Size by Functional Integration Type (2021-2026)
7.3.2 World AI in Pharmaceutical Market Size by Functional Integration Type (2027-2032)
7.3.3 World AI in Pharmaceutical Market Size Market Share by Functional Integration Type (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World AI in Pharmaceutical Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Drug Discovery and Design
8.2.2 Biomarker Identification
8.2.3 Clinical Trial Optimization
8.2.4 Manufacturing Process Optimization
8.2.5 Others
8.3 Market Segment by Application
8.3.1 World AI in Pharmaceutical Market Size by Application (2021-2026)
8.3.2 World AI in Pharmaceutical Market Size by Application (2027-2032)
8.3.3 World AI in Pharmaceutical Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Cradle
9.1.1 Cradle Details
9.1.2 Cradle Major Business
9.1.3 Cradle AI in Pharmaceutical Product and Services
9.1.4 Cradle AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Cradle Recent Developments/Updates
9.1.6 Cradle Competitive Strengths & Weaknesses
9.2 Prezent
9.2.1 Prezent Details
9.2.2 Prezent Major Business
9.2.3 Prezent AI in Pharmaceutical Product and Services
9.2.4 Prezent AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Prezent Recent Developments/Updates
9.2.6 Prezent Competitive Strengths & Weaknesses
9.3 Insilico Medicine
9.3.1 Insilico Medicine Details
9.3.2 Insilico Medicine Major Business
9.3.3 Insilico Medicine AI in Pharmaceutical Product and Services
9.3.4 Insilico Medicine AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Insilico Medicine Recent Developments/Updates
9.3.6 Insilico Medicine Competitive Strengths & Weaknesses
9.4 Owkin, Inc
9.4.1 Owkin, Inc Details
9.4.2 Owkin, Inc Major Business
9.4.3 Owkin, Inc AI in Pharmaceutical Product and Services
9.4.4 Owkin, Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Owkin, Inc Recent Developments/Updates
9.4.6 Owkin, Inc Competitive Strengths & Weaknesses
9.5 Certara
9.5.1 Certara Details
9.5.2 Certara Major Business
9.5.3 Certara AI in Pharmaceutical Product and Services
9.5.4 Certara AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Certara Recent Developments/Updates
9.5.6 Certara Competitive Strengths & Weaknesses
9.6 PathAI, Inc
9.6.1 PathAI, Inc Details
9.6.2 PathAI, Inc Major Business
9.6.3 PathAI, Inc AI in Pharmaceutical Product and Services
9.6.4 PathAI, Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 PathAI, Inc Recent Developments/Updates
9.6.6 PathAI, Inc Competitive Strengths & Weaknesses
9.7 Aizon
9.7.1 Aizon Details
9.7.2 Aizon Major Business
9.7.3 Aizon AI in Pharmaceutical Product and Services
9.7.4 Aizon AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Aizon Recent Developments/Updates
9.7.6 Aizon Competitive Strengths & Weaknesses
9.8 Salesforce, Inc
9.8.1 Salesforce, Inc Details
9.8.2 Salesforce, Inc Major Business
9.8.3 Salesforce, Inc AI in Pharmaceutical Product and Services
9.8.4 Salesforce, Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Salesforce, Inc Recent Developments/Updates
9.8.6 Salesforce, Inc Competitive Strengths & Weaknesses
9.9 Aidoc
9.9.1 Aidoc Details
9.9.2 Aidoc Major Business
9.9.3 Aidoc AI in Pharmaceutical Product and Services
9.9.4 Aidoc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Aidoc Recent Developments/Updates
9.9.6 Aidoc Competitive Strengths & Weaknesses
9.10 IQVIA
9.10.1 IQVIA Details
9.10.2 IQVIA Major Business
9.10.3 IQVIA AI in Pharmaceutical Product and Services
9.10.4 IQVIA AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 IQVIA Recent Developments/Updates
9.10.6 IQVIA Competitive Strengths & Weaknesses
9.11 ISOMORPHIC LABS
9.11.1 ISOMORPHIC LABS Details
9.11.2 ISOMORPHIC LABS Major Business
9.11.3 ISOMORPHIC LABS AI in Pharmaceutical Product and Services
9.11.4 ISOMORPHIC LABS AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 ISOMORPHIC LABS Recent Developments/Updates
9.11.6 ISOMORPHIC LABS Competitive Strengths & Weaknesses
9.12 ConcertAI
9.12.1 ConcertAI Details
9.12.2 ConcertAI Major Business
9.12.3 ConcertAI AI in Pharmaceutical Product and Services
9.12.4 ConcertAI AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 ConcertAI Recent Developments/Updates
9.12.6 ConcertAI Competitive Strengths & Weaknesses
9.13 Nexocode
9.13.1 Nexocode Details
9.13.2 Nexocode Major Business
9.13.3 Nexocode AI in Pharmaceutical Product and Services
9.13.4 Nexocode AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Nexocode Recent Developments/Updates
9.13.6 Nexocode Competitive Strengths & Weaknesses
9.14 BenevolentAI
9.14.1 BenevolentAI Details
9.14.2 BenevolentAI Major Business
9.14.3 BenevolentAI AI in Pharmaceutical Product and Services
9.14.4 BenevolentAI AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 BenevolentAI Recent Developments/Updates
9.14.6 BenevolentAI Competitive Strengths & Weaknesses
9.15 Recursion
9.15.1 Recursion Details
9.15.2 Recursion Major Business
9.15.3 Recursion AI in Pharmaceutical Product and Services
9.15.4 Recursion AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Recursion Recent Developments/Updates
9.15.6 Recursion Competitive Strengths & Weaknesses
9.16 Iktos
9.16.1 Iktos Details
9.16.2 Iktos Major Business
9.16.3 Iktos AI in Pharmaceutical Product and Services
9.16.4 Iktos AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Iktos Recent Developments/Updates
9.16.6 Iktos Competitive Strengths & Weaknesses
9.17 XtalPi Inc
9.17.1 XtalPi Inc Details
9.17.2 XtalPi Inc Major Business
9.17.3 XtalPi Inc AI in Pharmaceutical Product and Services
9.17.4 XtalPi Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 XtalPi Inc Recent Developments/Updates
9.17.6 XtalPi Inc Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 AI in Pharmaceutical Industry Chain
10.2 AI in Pharmaceutical Upstream Analysis
10.3 AI in Pharmaceutical Midstream Analysis
10.4 AI in Pharmaceutical Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World AI in Pharmaceutical Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World AI in Pharmaceutical Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World AI in Pharmaceutical Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World AI in Pharmaceutical Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World AI in Pharmaceutical Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI in Pharmaceutical Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World AI in Pharmaceutical Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World AI in Pharmaceutical Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World AI in Pharmaceutical Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key AI in Pharmaceutical Players in 2025
Table 12. World AI in Pharmaceutical Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global AI in Pharmaceutical Company Evaluation Quadrant
Table 14. Head Office of Key AI in Pharmaceutical Players
Table 15. AI in Pharmaceutical Market: Company Product Type Footprint
Table 16. AI in Pharmaceutical Market: Company Product Application Footprint
Table 17. AI in Pharmaceutical Mergers & Acquisitions Activity
Table 18. United States VS China AI in Pharmaceutical Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China AI in Pharmaceutical Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based AI in Pharmaceutical Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI in Pharmaceutical Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies AI in Pharmaceutical Revenue Market Share (2021-2026)
Table 23. China Based AI in Pharmaceutical Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI in Pharmaceutical Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies AI in Pharmaceutical Revenue Market Share (2021-2026)
Table 26. Rest of World Based AI in Pharmaceutical Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies AI in Pharmaceutical Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies AI in Pharmaceutical Revenue Market Share (2021-2026)
Table 29. World AI in Pharmaceutical Market Size by Deployment Type, (USD Million), 2021 & 2025 & 2032
Table 30. World AI in Pharmaceutical Market Size Value by Deployment Type (2021-2026) & (USD Million)
Table 31. World AI in Pharmaceutical Market Size by Deployment Type (2027-2032) & (USD Million)
Table 32. World AI in Pharmaceutical Market Size by Technology Type, (USD Million), 2021 & 2025 & 2032
Table 33. World AI in Pharmaceutical Market Size Value by Technology Type (2021-2026) & (USD Million)
Table 34. World AI in Pharmaceutical Market Size by Technology Type (2027-2032) & (USD Million)
Table 35. World AI in Pharmaceutical Market Size by Functional Integration Type, (USD Million), 2021 & 2025 & 2032
Table 36. World AI in Pharmaceutical Market Size Value by Functional Integration Type (2021-2026) & (USD Million)
Table 37. World AI in Pharmaceutical Market Size by Functional Integration Type (2027-2032) & (USD Million)
Table 38. World AI in Pharmaceutical Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World AI in Pharmaceutical Market Size by Application (2021-2026) & (USD Million)
Table 40. World AI in Pharmaceutical Market Size by Application (2027-2032) & (USD Million)
Table 41. Cradle Basic Information, Manufacturing Base and Competitors
Table 42. Cradle Major Business
Table 43. Cradle AI in Pharmaceutical Product and Services
Table 44. Cradle AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Cradle Recent Developments/Updates
Table 46. Cradle Competitive Strengths & Weaknesses
Table 47. Prezent Basic Information, Manufacturing Base and Competitors
Table 48. Prezent Major Business
Table 49. Prezent AI in Pharmaceutical Product and Services
Table 50. Prezent AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Prezent Recent Developments/Updates
Table 52. Prezent Competitive Strengths & Weaknesses
Table 53. Insilico Medicine Basic Information, Manufacturing Base and Competitors
Table 54. Insilico Medicine Major Business
Table 55. Insilico Medicine AI in Pharmaceutical Product and Services
Table 56. Insilico Medicine AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Insilico Medicine Recent Developments/Updates
Table 58. Insilico Medicine Competitive Strengths & Weaknesses
Table 59. Owkin, Inc Basic Information, Manufacturing Base and Competitors
Table 60. Owkin, Inc Major Business
Table 61. Owkin, Inc AI in Pharmaceutical Product and Services
Table 62. Owkin, Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Owkin, Inc Recent Developments/Updates
Table 64. Owkin, Inc Competitive Strengths & Weaknesses
Table 65. Certara Basic Information, Manufacturing Base and Competitors
Table 66. Certara Major Business
Table 67. Certara AI in Pharmaceutical Product and Services
Table 68. Certara AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Certara Recent Developments/Updates
Table 70. Certara Competitive Strengths & Weaknesses
Table 71. PathAI, Inc Basic Information, Manufacturing Base and Competitors
Table 72. PathAI, Inc Major Business
Table 73. PathAI, Inc AI in Pharmaceutical Product and Services
Table 74. PathAI, Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. PathAI, Inc Recent Developments/Updates
Table 76. PathAI, Inc Competitive Strengths & Weaknesses
Table 77. Aizon Basic Information, Manufacturing Base and Competitors
Table 78. Aizon Major Business
Table 79. Aizon AI in Pharmaceutical Product and Services
Table 80. Aizon AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Aizon Recent Developments/Updates
Table 82. Aizon Competitive Strengths & Weaknesses
Table 83. Salesforce, Inc Basic Information, Manufacturing Base and Competitors
Table 84. Salesforce, Inc Major Business
Table 85. Salesforce, Inc AI in Pharmaceutical Product and Services
Table 86. Salesforce, Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Salesforce, Inc Recent Developments/Updates
Table 88. Salesforce, Inc Competitive Strengths & Weaknesses
Table 89. Aidoc Basic Information, Manufacturing Base and Competitors
Table 90. Aidoc Major Business
Table 91. Aidoc AI in Pharmaceutical Product and Services
Table 92. Aidoc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Aidoc Recent Developments/Updates
Table 94. Aidoc Competitive Strengths & Weaknesses
Table 95. IQVIA Basic Information, Manufacturing Base and Competitors
Table 96. IQVIA Major Business
Table 97. IQVIA AI in Pharmaceutical Product and Services
Table 98. IQVIA AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. IQVIA Recent Developments/Updates
Table 100. IQVIA Competitive Strengths & Weaknesses
Table 101. ISOMORPHIC LABS Basic Information, Manufacturing Base and Competitors
Table 102. ISOMORPHIC LABS Major Business
Table 103. ISOMORPHIC LABS AI in Pharmaceutical Product and Services
Table 104. ISOMORPHIC LABS AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. ISOMORPHIC LABS Recent Developments/Updates
Table 106. ISOMORPHIC LABS Competitive Strengths & Weaknesses
Table 107. ConcertAI Basic Information, Manufacturing Base and Competitors
Table 108. ConcertAI Major Business
Table 109. ConcertAI AI in Pharmaceutical Product and Services
Table 110. ConcertAI AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. ConcertAI Recent Developments/Updates
Table 112. ConcertAI Competitive Strengths & Weaknesses
Table 113. Nexocode Basic Information, Manufacturing Base and Competitors
Table 114. Nexocode Major Business
Table 115. Nexocode AI in Pharmaceutical Product and Services
Table 116. Nexocode AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Nexocode Recent Developments/Updates
Table 118. Nexocode Competitive Strengths & Weaknesses
Table 119. BenevolentAI Basic Information, Manufacturing Base and Competitors
Table 120. BenevolentAI Major Business
Table 121. BenevolentAI AI in Pharmaceutical Product and Services
Table 122. BenevolentAI AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. BenevolentAI Recent Developments/Updates
Table 124. BenevolentAI Competitive Strengths & Weaknesses
Table 125. Recursion Basic Information, Manufacturing Base and Competitors
Table 126. Recursion Major Business
Table 127. Recursion AI in Pharmaceutical Product and Services
Table 128. Recursion AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Recursion Recent Developments/Updates
Table 130. Recursion Competitive Strengths & Weaknesses
Table 131. Iktos Basic Information, Manufacturing Base and Competitors
Table 132. Iktos Major Business
Table 133. Iktos AI in Pharmaceutical Product and Services
Table 134. Iktos AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Iktos Recent Developments/Updates
Table 136. Iktos Competitive Strengths & Weaknesses
Table 137. XtalPi Inc Basic Information, Manufacturing Base and Competitors
Table 138. XtalPi Inc Major Business
Table 139. XtalPi Inc AI in Pharmaceutical Product and Services
Table 140. XtalPi Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. XtalPi Inc Recent Developments/Updates
Table 142. XtalPi Inc Competitive Strengths & Weaknesses
Table 143. Global Key Players of AI in Pharmaceutical Upstream (Raw Materials)
Table 144. Global AI in Pharmaceutical Typical Customers
Table 1. World AI in Pharmaceutical Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World AI in Pharmaceutical Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World AI in Pharmaceutical Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World AI in Pharmaceutical Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World AI in Pharmaceutical Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI in Pharmaceutical Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World AI in Pharmaceutical Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World AI in Pharmaceutical Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World AI in Pharmaceutical Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key AI in Pharmaceutical Players in 2025
Table 12. World AI in Pharmaceutical Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global AI in Pharmaceutical Company Evaluation Quadrant
Table 14. Head Office of Key AI in Pharmaceutical Players
Table 15. AI in Pharmaceutical Market: Company Product Type Footprint
Table 16. AI in Pharmaceutical Market: Company Product Application Footprint
Table 17. AI in Pharmaceutical Mergers & Acquisitions Activity
Table 18. United States VS China AI in Pharmaceutical Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China AI in Pharmaceutical Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based AI in Pharmaceutical Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI in Pharmaceutical Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies AI in Pharmaceutical Revenue Market Share (2021-2026)
Table 23. China Based AI in Pharmaceutical Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI in Pharmaceutical Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies AI in Pharmaceutical Revenue Market Share (2021-2026)
Table 26. Rest of World Based AI in Pharmaceutical Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies AI in Pharmaceutical Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies AI in Pharmaceutical Revenue Market Share (2021-2026)
Table 29. World AI in Pharmaceutical Market Size by Deployment Type, (USD Million), 2021 & 2025 & 2032
Table 30. World AI in Pharmaceutical Market Size Value by Deployment Type (2021-2026) & (USD Million)
Table 31. World AI in Pharmaceutical Market Size by Deployment Type (2027-2032) & (USD Million)
Table 32. World AI in Pharmaceutical Market Size by Technology Type, (USD Million), 2021 & 2025 & 2032
Table 33. World AI in Pharmaceutical Market Size Value by Technology Type (2021-2026) & (USD Million)
Table 34. World AI in Pharmaceutical Market Size by Technology Type (2027-2032) & (USD Million)
Table 35. World AI in Pharmaceutical Market Size by Functional Integration Type, (USD Million), 2021 & 2025 & 2032
Table 36. World AI in Pharmaceutical Market Size Value by Functional Integration Type (2021-2026) & (USD Million)
Table 37. World AI in Pharmaceutical Market Size by Functional Integration Type (2027-2032) & (USD Million)
Table 38. World AI in Pharmaceutical Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World AI in Pharmaceutical Market Size by Application (2021-2026) & (USD Million)
Table 40. World AI in Pharmaceutical Market Size by Application (2027-2032) & (USD Million)
Table 41. Cradle Basic Information, Manufacturing Base and Competitors
Table 42. Cradle Major Business
Table 43. Cradle AI in Pharmaceutical Product and Services
Table 44. Cradle AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Cradle Recent Developments/Updates
Table 46. Cradle Competitive Strengths & Weaknesses
Table 47. Prezent Basic Information, Manufacturing Base and Competitors
Table 48. Prezent Major Business
Table 49. Prezent AI in Pharmaceutical Product and Services
Table 50. Prezent AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Prezent Recent Developments/Updates
Table 52. Prezent Competitive Strengths & Weaknesses
Table 53. Insilico Medicine Basic Information, Manufacturing Base and Competitors
Table 54. Insilico Medicine Major Business
Table 55. Insilico Medicine AI in Pharmaceutical Product and Services
Table 56. Insilico Medicine AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Insilico Medicine Recent Developments/Updates
Table 58. Insilico Medicine Competitive Strengths & Weaknesses
Table 59. Owkin, Inc Basic Information, Manufacturing Base and Competitors
Table 60. Owkin, Inc Major Business
Table 61. Owkin, Inc AI in Pharmaceutical Product and Services
Table 62. Owkin, Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Owkin, Inc Recent Developments/Updates
Table 64. Owkin, Inc Competitive Strengths & Weaknesses
Table 65. Certara Basic Information, Manufacturing Base and Competitors
Table 66. Certara Major Business
Table 67. Certara AI in Pharmaceutical Product and Services
Table 68. Certara AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Certara Recent Developments/Updates
Table 70. Certara Competitive Strengths & Weaknesses
Table 71. PathAI, Inc Basic Information, Manufacturing Base and Competitors
Table 72. PathAI, Inc Major Business
Table 73. PathAI, Inc AI in Pharmaceutical Product and Services
Table 74. PathAI, Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. PathAI, Inc Recent Developments/Updates
Table 76. PathAI, Inc Competitive Strengths & Weaknesses
Table 77. Aizon Basic Information, Manufacturing Base and Competitors
Table 78. Aizon Major Business
Table 79. Aizon AI in Pharmaceutical Product and Services
Table 80. Aizon AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Aizon Recent Developments/Updates
Table 82. Aizon Competitive Strengths & Weaknesses
Table 83. Salesforce, Inc Basic Information, Manufacturing Base and Competitors
Table 84. Salesforce, Inc Major Business
Table 85. Salesforce, Inc AI in Pharmaceutical Product and Services
Table 86. Salesforce, Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Salesforce, Inc Recent Developments/Updates
Table 88. Salesforce, Inc Competitive Strengths & Weaknesses
Table 89. Aidoc Basic Information, Manufacturing Base and Competitors
Table 90. Aidoc Major Business
Table 91. Aidoc AI in Pharmaceutical Product and Services
Table 92. Aidoc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Aidoc Recent Developments/Updates
Table 94. Aidoc Competitive Strengths & Weaknesses
Table 95. IQVIA Basic Information, Manufacturing Base and Competitors
Table 96. IQVIA Major Business
Table 97. IQVIA AI in Pharmaceutical Product and Services
Table 98. IQVIA AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. IQVIA Recent Developments/Updates
Table 100. IQVIA Competitive Strengths & Weaknesses
Table 101. ISOMORPHIC LABS Basic Information, Manufacturing Base and Competitors
Table 102. ISOMORPHIC LABS Major Business
Table 103. ISOMORPHIC LABS AI in Pharmaceutical Product and Services
Table 104. ISOMORPHIC LABS AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. ISOMORPHIC LABS Recent Developments/Updates
Table 106. ISOMORPHIC LABS Competitive Strengths & Weaknesses
Table 107. ConcertAI Basic Information, Manufacturing Base and Competitors
Table 108. ConcertAI Major Business
Table 109. ConcertAI AI in Pharmaceutical Product and Services
Table 110. ConcertAI AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. ConcertAI Recent Developments/Updates
Table 112. ConcertAI Competitive Strengths & Weaknesses
Table 113. Nexocode Basic Information, Manufacturing Base and Competitors
Table 114. Nexocode Major Business
Table 115. Nexocode AI in Pharmaceutical Product and Services
Table 116. Nexocode AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Nexocode Recent Developments/Updates
Table 118. Nexocode Competitive Strengths & Weaknesses
Table 119. BenevolentAI Basic Information, Manufacturing Base and Competitors
Table 120. BenevolentAI Major Business
Table 121. BenevolentAI AI in Pharmaceutical Product and Services
Table 122. BenevolentAI AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. BenevolentAI Recent Developments/Updates
Table 124. BenevolentAI Competitive Strengths & Weaknesses
Table 125. Recursion Basic Information, Manufacturing Base and Competitors
Table 126. Recursion Major Business
Table 127. Recursion AI in Pharmaceutical Product and Services
Table 128. Recursion AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Recursion Recent Developments/Updates
Table 130. Recursion Competitive Strengths & Weaknesses
Table 131. Iktos Basic Information, Manufacturing Base and Competitors
Table 132. Iktos Major Business
Table 133. Iktos AI in Pharmaceutical Product and Services
Table 134. Iktos AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Iktos Recent Developments/Updates
Table 136. Iktos Competitive Strengths & Weaknesses
Table 137. XtalPi Inc Basic Information, Manufacturing Base and Competitors
Table 138. XtalPi Inc Major Business
Table 139. XtalPi Inc AI in Pharmaceutical Product and Services
Table 140. XtalPi Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. XtalPi Inc Recent Developments/Updates
Table 142. XtalPi Inc Competitive Strengths & Weaknesses
Table 143. Global Key Players of AI in Pharmaceutical Upstream (Raw Materials)
Table 144. Global AI in Pharmaceutical Typical Customers
LIST OF FIGURES
Figure 1. AI in Pharmaceutical Picture
Figure 2. World AI in Pharmaceutical Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World AI in Pharmaceutical Total Revenue (2021-2032) & (USD Million)
Figure 4. World AI in Pharmaceutical Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World AI in Pharmaceutical Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company AI in Pharmaceutical Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company AI in Pharmaceutical Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company AI in Pharmaceutical Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company AI in Pharmaceutical Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company AI in Pharmaceutical Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company AI in Pharmaceutical Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company AI in Pharmaceutical Revenue (2021-2032) & (USD Million)
Figure 13. AI in Pharmaceutical Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI in Pharmaceutical Consumption Value (2021-2032) & (USD Million)
Figure 16. World AI in Pharmaceutical Consumption Value Market Share by Region (2021-2032)
Figure 17. United States AI in Pharmaceutical Consumption Value (2021-2032) & (USD Million)
Figure 18. China AI in Pharmaceutical Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe AI in Pharmaceutical Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan AI in Pharmaceutical Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea AI in Pharmaceutical Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN AI in Pharmaceutical Consumption Value (2021-2032) & (USD Million)
Figure 23. India AI in Pharmaceutical Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of AI in Pharmaceutical by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI in Pharmaceutical Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI in Pharmaceutical Markets in 2025
Figure 27. United States VS China: AI in Pharmaceutical Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: AI in Pharmaceutical Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World AI in Pharmaceutical Market Size by Deployment Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World AI in Pharmaceutical Market Size Market Share by Deployment Type in 2025
Figure 31. Cloud-Based AI Solutions
Figure 32. On-Premises AI Platforms
Figure 33. World AI in Pharmaceutical Market Size Market Share by Deployment Type (2021-2032)
Figure 34. World AI in Pharmaceutical Market Size by Technology Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World AI in Pharmaceutical Market Size Market Share by Technology Type in 2025
Figure 36. Machine Learning AI
Figure 37. Deep Learning AI
Figure 38. Natural Language Processing (NLP)
Figure 39. Computer Vision AI
Figure 40. Others
Figure 41. World AI in Pharmaceutical Market Size Market Share by Technology Type (2021-2032)
Figure 42. World AI in Pharmaceutical Market Size by Functional Integration Type, (USD Million), 2021 & 2025 & 2032
Figure 43. World AI in Pharmaceutical Market Size Market Share by Functional Integration Type in 2025
Figure 44. Drug Discovery AI Platforms
Figure 45. Clinical Trial AI Systems
Figure 46. Manufacturing Process AI
Figure 47. Regulatory Compliance AI
Figure 48. Others
Figure 49. World AI in Pharmaceutical Market Size Market Share by Functional Integration Type (2021-2032)
Figure 50. World AI in Pharmaceutical Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World AI in Pharmaceutical Market Size Market Share by Application in 2025
Figure 52. Drug Discovery and Design
Figure 53. Biomarker Identification
Figure 54. Clinical Trial Optimization
Figure 55. Manufacturing Process Optimization
Figure 56. Others
Figure 57. World AI in Pharmaceutical Market Size Market Share by Application (2021-2032)
Figure 58. AI in Pharmaceutical Industrial Chain
Figure 59. Methodology
Figure 60. Research Process and Data Source
Figure 1. AI in Pharmaceutical Picture
Figure 2. World AI in Pharmaceutical Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World AI in Pharmaceutical Total Revenue (2021-2032) & (USD Million)
Figure 4. World AI in Pharmaceutical Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World AI in Pharmaceutical Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company AI in Pharmaceutical Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company AI in Pharmaceutical Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company AI in Pharmaceutical Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company AI in Pharmaceutical Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company AI in Pharmaceutical Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company AI in Pharmaceutical Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company AI in Pharmaceutical Revenue (2021-2032) & (USD Million)
Figure 13. AI in Pharmaceutical Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI in Pharmaceutical Consumption Value (2021-2032) & (USD Million)
Figure 16. World AI in Pharmaceutical Consumption Value Market Share by Region (2021-2032)
Figure 17. United States AI in Pharmaceutical Consumption Value (2021-2032) & (USD Million)
Figure 18. China AI in Pharmaceutical Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe AI in Pharmaceutical Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan AI in Pharmaceutical Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea AI in Pharmaceutical Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN AI in Pharmaceutical Consumption Value (2021-2032) & (USD Million)
Figure 23. India AI in Pharmaceutical Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of AI in Pharmaceutical by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI in Pharmaceutical Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI in Pharmaceutical Markets in 2025
Figure 27. United States VS China: AI in Pharmaceutical Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: AI in Pharmaceutical Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World AI in Pharmaceutical Market Size by Deployment Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World AI in Pharmaceutical Market Size Market Share by Deployment Type in 2025
Figure 31. Cloud-Based AI Solutions
Figure 32. On-Premises AI Platforms
Figure 33. World AI in Pharmaceutical Market Size Market Share by Deployment Type (2021-2032)
Figure 34. World AI in Pharmaceutical Market Size by Technology Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World AI in Pharmaceutical Market Size Market Share by Technology Type in 2025
Figure 36. Machine Learning AI
Figure 37. Deep Learning AI
Figure 38. Natural Language Processing (NLP)
Figure 39. Computer Vision AI
Figure 40. Others
Figure 41. World AI in Pharmaceutical Market Size Market Share by Technology Type (2021-2032)
Figure 42. World AI in Pharmaceutical Market Size by Functional Integration Type, (USD Million), 2021 & 2025 & 2032
Figure 43. World AI in Pharmaceutical Market Size Market Share by Functional Integration Type in 2025
Figure 44. Drug Discovery AI Platforms
Figure 45. Clinical Trial AI Systems
Figure 46. Manufacturing Process AI
Figure 47. Regulatory Compliance AI
Figure 48. Others
Figure 49. World AI in Pharmaceutical Market Size Market Share by Functional Integration Type (2021-2032)
Figure 50. World AI in Pharmaceutical Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World AI in Pharmaceutical Market Size Market Share by Application in 2025
Figure 52. Drug Discovery and Design
Figure 53. Biomarker Identification
Figure 54. Clinical Trial Optimization
Figure 55. Manufacturing Process Optimization
Figure 56. Others
Figure 57. World AI in Pharmaceutical Market Size Market Share by Application (2021-2032)
Figure 58. AI in Pharmaceutical Industrial Chain
Figure 59. Methodology
Figure 60. Research Process and Data Source
